Immucor to Announce Fiscal Second Quarter 2011 Financial Results on Thursday, January 6, 2011

This version of Wbna40785199 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

NORCROSS, Ga., Dec. 22, 2010 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal 2011 second quarter earnings on Thursday, January 6, 2011 after the market close. The Company will host a conference call on Friday, January 7, 2011 at 8:30 a.m. (Eastern Time) to discuss the results.

NORCROSS, Ga., Dec. 22, 2010 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal 2011 second quarter earnings on Thursday, January 6, 2011 after the market close. The Company will host a conference call on Friday, January 7, 2011 at 8:30 a.m. (Eastern Time) to discuss the results.

Investors are invited to participate in this conference call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also access the call via Webcast through the "Investor Relations" section at www.immucor.com. A copy of the press release will be available at the same Web address.

For those unable to listen to the live broadcast, a replay of the conference call will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days. Additionally, investors may access a replay of the call for one week beginning at noon on January 7th by dialing 1-866-469-5762 (Passcode: 4756).

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

CONTACT: Immucor, Inc. Michele Howard 770-441-2051
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone